Xing J - Search Results

1

Pan-cancer analysis of DCTN2 and its tumour-promoting role in HCC by modulating the AKT pathway.

Xu S, Xing J, Li K, Qiao L, Zhang C, Ren Y, Liu Y. Xu S, et al. Among authors: xing j. J Cell Mol Med. 2024 Jun;28(11):e18450. doi: 10.1111/jcmm.18450. J Cell Mol Med. 2024. PMID: 38842133 Free PMC article.

2

Classification of Signature-Based Phenotypes of Aging-Related Genes to Identify Prognostic and Immune Characteristics in HCC.

Zhao J, Li C, Li Q, Shen S, Hu X, Dong Z, Zhang Y, Xing J. Zhao J, et al. Among authors: xing j. Anal Cell Pathol (Amst). 2023 Mar 20;2023:5735339. doi: 10.1155/2023/5735339. eCollection 2023. Anal Cell Pathol (Amst). 2023. PMID: 36994451 Free PMC article.

3

Xing J, Shen S, Liu X, Zhang Y. Xing J, et al. Biosci Rep. 2022 Nov 30;42(11):BSR20221089. doi: 10.1042/BSR20221089. Biosci Rep. 2022. PMID: 36314455 Free PMC article.

4

Vaccinia virus expressing IL-37 promotes antitumor immune responses in hepatocellular carcinoma.

Zhang Z, Zhang J, Zhang Y, Xing J, Yu Z. Zhang Z, et al. Among authors: xing j. Cell Biochem Funct. 2019 Dec;37(8):618-624. doi: 10.1002/cbf.3438. Epub 2019 Nov 11. Cell Biochem Funct. 2019. PMID: 31710117

5

Construction and evaluation of an aging-associated genes-based model for pancreatic adenocarcinoma prognosis and therapies.

Zhao J, Guan K, Xing J. Zhao J, et al. Among authors: xing j. Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231172072. doi: 10.1177/03946320231172072. Int J Immunopathol Pharmacol. 2023. PMID: 37072128 Free PMC article.

6

Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq.

Liu X, Li J, Wang Q, Bai L, Xing J, Hu X, Li S, Li Q. Liu X, et al. Among authors: xing j. Front Immunol. 2022 Oct 13;13:1012303. doi: 10.3389/fimmu.2022.1012303. eCollection 2022. Front Immunol. 2022. PMID: 36311759 Free PMC article.

7

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.

Xu L, Gao X, Xing J, Guo Z. Xu L, et al. Among authors: xing j. Front Immunol. 2023 Mar 2;14:1118816. doi: 10.3389/fimmu.2023.1118816. eCollection 2023. Front Immunol. 2023. PMID: 36936916 Free PMC article.

8

N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.

Shen S, Yan J, Zhang Y, Dong Z, Xing J, He Y. Shen S, et al. Among authors: xing j. Ann Transl Med. 2021 Jan;9(1):59. doi: 10.21037/atm-20-7396. Ann Transl Med. 2021. PMID: 33553352 Free PMC article.

9

Long Non-coding RNA Small Nucleolar RNA Host Gene 14, a Promising Biomarker and Therapeutic Target in Malignancy.

Shen S, Wang Y, Zhang Y, Dong Z, Xing J. Shen S, et al. Among authors: xing j. Front Cell Dev Biol. 2021 Sep 23;9:746714. doi: 10.3389/fcell.2021.746714. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34631721 Free PMC article. Review.

10

Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma.

Xu L, Chen S, Li Q, Chen X, Xu Y, Zhou Y, Li J, Guo Z, Xing J, Chen D. Xu L, et al. Among authors: xing j. Cancer Cell Int. 2024 Jan 13;24(1):30. doi: 10.1186/s12935-023-03208-x. Cancer Cell Int. 2024. PMID: 38218909 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,419 results

Search Page

Filters